“Albutrepenonacog Alfa (Idelvion®) for the Treatment of Italian Patients With Hemophilia B: A Budget Impact Model”. Farmeconomia. Health Economics and Therapeutic Pathways 19, no. 1 (January 30, 2018). Accessed February 15, 2026. https://journals.seedstm.com/index.php/FE/article/view/1328.